Taylor Sandison
Chief Medical Officer, Cidara Therapeutics.
Companies
- Cidara TherapeuticsChief Medical Officer Mar 31, 2017 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Cidara Therapeutics CDTX23,067 shares2Sep 11, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 11, 2024Sold 924 shares at $11.64 of Cidara Therapeutics2
- Mar 15, 2024Granted 128,750 shares of Cidara Therapeutics3
- Mar 11, 2024Sold 20,662 shares at $0.67 of Cidara Therapeutics4
- Sep 11, 2023Sold 18,793 shares at $0.95 of Cidara Therapeutics5
- Mar 27, 2023Granted 90,000 shares of Cidara Therapeutics6
- Mar 13, 2023Sold 7,203 shares at $1.53 of Cidara Therapeutics7
- Sep 12, 2022Sold 18,478 shares at $0.68 of Cidara Therapeutics8
- Mar 31, 2022Granted 50,000 shares of Cidara Therapeutics9
- Dec 29, 2021Exercised options 15,600 shares of Cidara Therapeutics10
- Sep 30, 2021Granted 150,600 shares of Cidara Therapeutics11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 20, 2024
- 4SEC EDGARForm 4 filed Mar 12, 2024
- 5SEC EDGARForm 4 filed Sep 13, 2023
- 6SEC EDGARForm 4 filed Mar 29, 2023
- 7SEC EDGARForm 4 filed Mar 13, 2023
- 8SEC EDGARForm 4 filed Sep 13, 2022
- 9SEC EDGARForm 4 filed Apr 4, 2022
- 10SEC EDGARForm 4 filed Jan 7, 2022
- 11SEC EDGARForm 4 filed Oct 4, 2021